Literature DB >> 10683836

Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules.

E Zeinstra1, N Wilczak, C Streefland, J De Keyser.   

Abstract

To initiate the inflammatory cascade leading to demyelination in multiple sclerosis (MS) T cells have to recognize their specific myelin antigen, which needs to be presented in the context of major histocompatibility (MHC) class II molecules expressed on antigen presenting cells. Whether astrocytes can express MHC class II molecules in vivo is a controversial issue. We performed double labeling immunohistochemistry in postmortem samples from nine patients with MS, three patients with a cerebral infarction and six controls. Astrocytes in controls, in normal appearing white matter in MS, and at the boundary of infarctions were MHC class II negative. In contrast, a subset of astrocytes in active chronic plaques immunostained for MHC class II, indicating potential antigen presenting interactions of astrocytes in MS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683836     DOI: 10.1097/00001756-200001170-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

Review 1.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Astrocyte, the star avatar: redefined.

Authors:  Pankaj Seth; Nitin Koul
Journal:  J Biosci       Date:  2008-09       Impact factor: 1.826

Review 3.  Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity.

Authors:  Ari Waisman; Lisa Johann
Journal:  J Mol Med (Berl)       Date:  2018-11-01       Impact factor: 4.599

4.  Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.

Authors:  Paul D Storer; Jihong Xu; Janet A Chavis; Paul D Drew
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

5.  Role of the MHC2TA gene in autoimmune diseases.

Authors:  Alfonso Martínez; Marta Sánchez-Lopez; Jezabel Varadé; Ana Mas; M Carmen Martín; Virginia de Las Heras; Rafael Arroyo; Juan Luis Mendoza; Manuel Díaz-Rubio; Benjamín Fernández-Gutiérrez; Emilio G de la Concha; Elena Urcelay
Journal:  Ann Rheum Dis       Date:  2006-09-29       Impact factor: 19.103

Review 6.  Glial grafting for demyelinating disease.

Authors:  V Tepavcević; W F Blakemore
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

7.  CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.

Authors:  Yingru Liu; Yoshio Bando; David Vargas-Lowy; Wassim Elyaman; Samia J Khoury; Tao Huang; Karin Reif; Tanuja Chitnis
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

8.  Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.

Authors:  Walter Royal; Li Zhang; Ming Guo; Odell Jones; Harry Davis; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2012-04-12       Impact factor: 3.478

9.  Fingolimod Suppresses the Proinflammatory Status of Interferon-γ-Activated Cultured Rat Astrocytes.

Authors:  Saša Trkov Bobnar; Matjaž Stenovec; Katarina Miš; Sergej Pirkmajer; Robert Zorec
Journal:  Mol Neurobiol       Date:  2019-01-30       Impact factor: 5.590

10.  Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration.

Authors:  Shahid Salaria; Haleh Badkoobehi; Edward Rockenstein; Leslie Crews; Gursharan Chana; Eliezer Masliah; Ian P Everall
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.